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Patients with congestive heart failure have abnormal rroaarv
hemodynamics, characterized by decreased coronary sinus oxygen
content, increased coronary sinus blood flow and increased moo.
cordial oxygen consumption. To evaluate their prognostic impor.
lanee, the clinical characteristics and systemic and coronary
hemodynamics were related to survival in 91 patients with severe
congestive heart failure and decreased ejection traction 125.5 a
10% [mean ±
SDI) .
In 69 patients congestive heart failure was due
to or secondary to coronary artery disease (group 1) and in 22 it
was due to idiopathic dilated cardiomyopathy, (group 2) . Five
patients were in functional class 11, 48 in class
III and 38 in class
IV
. The median survival lime was 20.7 months.
As assessed with the Cox proportional hazards model, coro-
nary sinus oxygen content was mast strongly associated with a
poor prognosis. On the basis of a comparison between the lowest
p
Severe congestive heart failure is a malignant cardiac syn-
drome that carries a very Door prognosis . With conven oral
harmacotherapy (digitalis and diuretic drugs) . the d -year
mortality rate is approximately 50% (1 .2) . and even with the
addition of vasodilators and angiotensin-converting enzyme
inhibitors mortality may exceed 30% by the
end if I year (3) .
Several prognostic factors to identify these high risk patients
have been reported in an attempt to select
patients appro-
priate for cardiac transplantation and other aggressive ther-
apy . Deteriorating clinical status (New York Hem t Associ-
ation functional class IV), severity of decrease
in left
ventricular function, hyponatremia and neuroendocrine dys-
function, such as an increased level of norepinephrine and
plasma resin activity, have been recognized to adversely
influence ,rrognosis (4-10),
From the Univervity 4 011- Haas Iromulc . Ouus ., . Onnrio, Canada,
She Centre do Recherche . Division of Cardiology . Hopiwl du SacTe Co-de
Manned, Mnniecel . Qu e hee and -The Ikparoent of AIoJicine. Di .oum of
Cardiology . Cniverdity of Cahforniz ,n .Son Frami,co, S:ul Francisco . C:di-
foes, . Dr while is a research feam, of th e Hoot and Stroke Found .num of
Cancdo,ouawa,Onwdo .
Manuscript received December i
. 19911,
r«i,oo nlonu,cnpl rcaai,ed Muy
ya, 1991 . aeepled June 6 .101
Add ,
e-
for royr1u Kxnu Chatterjcc, NIB . FRCP . CUSP Mvical
Center, list, Mothu Hospital, San For-- California 94143 .
61011
byrho American Culkpe ofCarau,logy
1631
(coronary sinus oxygen content 04.44 voR%) and highest quintile
(coronary sinus oxygen content >4 .44 vol°e), a Iosr coronary sinus
oxygen content was associated with a 2.34-fold increased risk of
dying (95ra confidence interval, 1 .31 to 4 .08) . A low systolic blood
pressure and a high diastolic pulmonary artery
pressure were also
significantly associated with increased mortality . Patients in the
subgroup with a low coronary sinus oxygen content had values for
functional class, ejection fraction
and systemic hemodynamics
similar to those of patients in the subgroup with high coronary
sinus oxygen content .
It is concluded that a low coronary sinus oxygen content
indicative of nancompensated metabolic demand suggests a poor
prognosis in patients with severe congestive heart failure.
(f Am
Col) Cardiol 1991;)R:1631-7)
In patients with severe congestive heart failure, abnor-
malities not only of systemic hemodynamics but also of
coronary hemodynamics and myocardial energetics have
been documented (11) . An increase in myocardial oxygen
consumption and abnormalities of myocardial lactate metab-
olism can occur even at rest in patients with
severe conges-
tive heart failure resulting from impaired systolic function
(II). Such abnormalities can occur in patients with and
without atherosclerotic obstructive coronary artery disease .
However . the significance of abnormal coronary hemody-
namics, particularly in relation to the prognosis of patients
with severe congestive heart failure, has not been clarified .
The purpose of this study
was to correlate the different
variables of rest coronary hemodynamics with survival in
two groups of patients with congestive heart failure : those
with (ischemic cardiomyopathy) and without (idiopmhic
dilated cardiamyopathy) coronary
artery disease.
Methods
Study patients. The study group consisted of 91 patients
r,ith congestive heart failure . There were S patients in New
York Heart Association functional class 11, 48 in class III
and 38 in class iy' . Group I comprised 69 patients with
coronary artery disease documented by myocardial jnfarc-
0775-1a97M,13.5a
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Lion or coronary angiographyg or both ; none of these patients
Table 1 . Clinical Characteristics of 91 Patients'
had significant angina . Group 2 comprised 22 patients with
idiopathic dilated cardiomyopathy .
The patients were studied at the Cardiovascular Research
Institute at the University of California in San Francisco and
Sacre-Coeur Hospital in Montreal between 1980 and 1984 ;
the study was terminated in 1988 and the data were retro-
spectively analyzed. The coronary hemodynamic findings in
some of the patients in this study have been previously
reported (I I) .
Study protocol . All patients were studied in the cardiac
care unit under rest conditions in a nonsedated, fasting state
after giving written, informed consent. They were receiving
maintenance therapy of 2 glday of sodium and stable doses
of digoxin and diuretics ; nitrates were discontinued for
?12 h and other vasodilators for ?24 h before the study .
The sladv procedure has previously been described (Il ) .
A triple-lumen thermodilution balloon flotation catheter was
placed in the pulmonary artery and cardiac output was
determined in triplicate by the thermodilution technique .
Arterial blood pressure was recorded by radial artery canula .
A double-thermistor coronary sinus catheter was introduced
percutaneously by way of the left subclavian vein into the
coronary sinus to measure coronary blood flow by the
constant infusion thermodilution technique
; the catheter
position was ensured with a small bolus injection of contrast
medium and significant reflux was excluded by monitoring
the coronary sinus temperature after injection of 10 nil of
iced saline solution in the right atrium before and after the
study. Two sets of rest systemic and coronary hemodynamic
measurements were recorded and arterial and coronary
sinus blood samples drawn .
Calculations . The derived systemic and coronary
hemodynamic variables were calculated in this manner :
systemic vascular resistance (SVR[dynes-s'cm -5]) _
(MAP - RAP)ICO x 80, where MAP = mean arterial
pressure (mm Hg), RAP = right atrial pressure (mm Hg) and
CO = cardiac output (liters/min)
. Pulmonary vascular resis-
tance (PVR[dynes .s-cm -5 ]) _ (PAP - PCWP)ICO x 80,
where PAP = mean pulmonary artery pressure (mm Hg) and
PCWP = pulmonary apillary wedge pressure (mm Hg) .
Coronary sinus blood flow (CSBF[ml/min]) _ (Tb - Ti/Tb -
Troy - 1 .08 x 46 ml/min, where Tb = temperature of blood,
Ti = temperature of injeclate, Too = temperature of mixture
of blood and indicator, 1 .08 is
a constant accounting for the
specific heat and density of blood and indicator and
46 ml/min is the injection rate of the indicator .
Oxygen saturations were measured with a Corning 175
automated blood and pH analyzer . Lactate concentra]ions
were measured by enzymatic spectrofluorometric technique
.
The derived metabolic variables were calculated in this way :
Myocardial oxygen consumption (MVO zlmllmin]) = (Arte-
rial -
Coronary sinus oxygen content) x Coronary sinus
flow x 10 -3 . Myocardial lactate extraction (%) = (Arterial -
Coronary sinus lactate content/Arterial lactate) x 100 .
Continuous variuhles are expressed as mean values x SD (in pureeltlo
.
see). 'None of the group differences are significant . tValues in parentheses
are percents. Ir = 63 . ACE - angiotensin convening enzyme inhibitor .
CAD = coronary artery disease ; HytNit = hydmlazine or nitrate . or both :
NYHA = New York Heart Association functional class .
Statistical analysis. All data analysis was performed with
use of the Statistical Analysis System (SAS). To assess
survival distributions in both ischemic and idiopathic cardio-
myopathy groups, actuarial estimates (Kaplan-Meier) were
computed and plotted . To assess covariate influences on
predicting survival the Cox proportional hazard model was
used, adjusting for baseline differences between the two
patient groups . Multiplicity was controlled by using the
Bonferroni adjustment. When appropriate, 95% confidence
intervals were computed. All probability (p) values 55%
were considered statistically significant. All values are ex-
pressed as mean values ± SD .
Results
Study group . Table I describes the clinical characteris-
tics of all 91 patients in the total study group and for group I
(69 patients with coronary artery disease) and group 2 (22
patients with idiopathic dilated cardiomyopathy) . All pa-
tients had a low ejection fraction and were receiving high
doses of furosemide; 95% were in functional class III or IV ;
36% were taking an angiotensin-converting enzyme inhibi-
tor, 37% digoxin and 23% hydralazine or a nitrate, or both .
There were no statistical differences in these variables
between the two groups .
Survival and systemic and coronary hemodynamics (Tables
2 to 4). All patients had elevated pulmonary artery, pulmo-
nary capillary wedge and right atria) pressure, increased
systemic and pulmonary vascular resistance and decreased
cardiac output (Table 2) . There were no differences in
systemic hemodynamics between group I and group 2 pa-
tients. The coronary hemodynamics were also similar in the
Total Group
Group I
(CADI
Group 2
(idiopathic
cardiomyopathy)
No . ofpalieels 91 69 22
Age (yr) 64 65(10) 60110.1)
NYHA class )s)t
II 5 (5 .5) 4 (5 .81 1 (45)
111 48 (52 .71 33 (47.8) 15 168.2)
IV 38 (41 .8) 3206.41 6127.31
Medications (Ot
ACE 36 (39.6) 27 09. 1) 9(40,9)
Digoxin 34 (37.4) 24 (34.8) 10 (45.5)
HylNit 21(23.1) 18(26.1) 3(13.6)
Furosemide (my/day) 127186) 131(88) 115 (78)
Ejection fraction (%)t 25 .5 r9.5) 26 .5 (8.8) 21 .8 )11.1)
Fallow-up (ma)
Mean
42 43 38
Range 0 .2-96 0 .2-96 0.2-77
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Table 2. Systemic and Coronary Hemodynamics'
Table 3. Coy Pruporliunal Hazards Model
Group 2
Values are mean
-
SD (in parentheses) .'Noea of the group difference,
are significant . CO = cardiac output : C5BF = coronar y sinus bland Dow :
CSO, = coronary in., oxygen 0501051. 0RP - 9-la, Shod prc»urc :
ext=extraction; HR=heartrete;MVO,
-
myocardialuxvgencon,amptioa .
PADP = pulmonary artery diastolic pie suure: PASP = pulmonary artery
systolic pressure: PCWP = pulmonary capillan „edge pressure : PVR =
pulmonary vascular resistance : RAP = right sooal
pot-- SBP = systolic
blood pressure: SVR = xysremic vascular rcsmncc . 01her abbteu atica, as
in game r
.
two groups . There were no differences in coronary sinus
blood flow, myocardial oxygen consumption, coronary sinus
oxygen content and myocardial lactate extraction .
Figure I illustrates the survival distribution of the 91
patients in the study group . The median survival time of the
91 patients was 2(3.7 months; 45% were alive at 2 years 195%
confidence interval 27
.8% to 62
.9%) . The median survival
time was 20 .6 months for the patients in group I and 27
months for the patients in group 2 (p = NS), By the end of
the study, 58 patients had died and 33 patients were alive .
The clinical variables and systemic and coronary hemo-
dynamics were related to survival as assessed by the Cox
proportional hazards model (Table 3) . Coronary sinus oxy-
gen content had the strongest association with poor survival :
on the basis of the comparison between the lower and upper
quintile, a low coronary sinus oxygen content was associ-
ated with a 2,34-fold increased risk of dying (95% confidence
interval 1 .96 to 5.81) . Similarly. patients with a higher
systolic blood pressure had a decreased mortality (relative
risk of dying 0 .50; 93% confidence interval 0.29 to 0.89) . A
higher pulmonary artery diastolic pressure was also signifi-
cantly associated with an adverse outcome 'relative risk
1
.95:95% confidence interval 1
.12 to 3
.40) . Finally, patients
with a higher functional class tended to have an increased
mortality (p = 0
.08) (relative
risk
of dying 1
.62
; 959 confi-
dence interval 0.94 to 2 .79).
Table 4 illusrrate.e the clinical, s_stemit and eonmarv
h modyrtornic
I
irriables for the smdv group divided into to,
subgroups
of patients w'th low and high coronary sinus
1633
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risk:
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oxygen content on the basis of the mean value of coronary
sinus oxygen consent. The clinical variables were simliar In
the two subgroups : the subgroup with a low coronary sinus
oxygen content had lower cardiac output and higher pulmo-
nary artery pressure, pulmonary capillary wedge pressure
and pulmonary and systemic vascular resistance: however,
none of these variables reached statistical significance . No
differences were observed in myocardial oxygen consump-
tion, coronary sinus blood flow and lactate extraction he-
hveen the two subgroups,
Figure 2 illustrates that a lower coronary sinus oxygen
content was associated with a significantly increased mor-
tality (generalized Wilcoxon statistic . p s 0.0001) : 80% of
patients with a high coronary sinus oxygen content were
alive al 12 months in comparison with 40% of those with a
low coronary sinus oxygen content .
Figure 3 illustrates the survival distribution for patients in
groups I and '_, subdivided into four subgroups on the basis
of the mean value for coronary sinus oxygen content
. Again .
there is a marked difference in survival between the patients
in the subgroups with high and low coronary sinus oxygen
content (p < 0.0005)
. Patients in both group I and group 2
demonstrated an adverse prc nosis related to a low coronary
sinus oxygen content.
Discussion
Role of
coronary sinus oxygen content in survival . This
study demonstrates that the coronary sinus oxygen content
Variable 00101 Group
Group I
ICADI
tidmpuhia
cueliomyopath0I
HR (bealslmin) 86(18) 860191 861161
SBP (mm Ho) 133 1294 I3t(28) 127(32)
DBP(mmHg( 67(12) 511111 691131
PASP1mnHg) 581171 601181 515151
POOP into Hg)
28181 28181 2719)
RAP met Hg) II 161 11 16, 10 171
PCWP
Item H81 75181 225181 224110)
CO (llteilminl 4 .10 .11 3.90 11 441 .9
SVRldynerstm s) 1.64316001 1,683 (562) 1,5161707)
PVRldynres-cm `I 275(158) 294(1651 21511141
MVO,lmllminl 125(8.6) 11 .50_51 (5 .64445
CSO.(v01S.) 4.401 .6) 4 .62 21191 1951 .81
CSBP (mpmie1 1041551 101 1450 114 71,
Lactate 'x1 (91) 26 (31) 25 (25) 11 )401
Vanab1,
Areroximale
-chiSquare P Vale lo, Likchhood
.Sge 1.36 0.0168 - 222.3'69
Dx 0 0.9712 -2 2 4,5554
NY0I .A 1,77 00053 -211)6696
HR 0 .37 01431 -2245717
SBP
8 .99 000'-' -220.0159
PASP 808 0 .001 -'_205181
PADP
939 1.0122 -219$597
PCWP 0.0238
-2' 00
:4
Co 0.19 06669 461'
SIR
1 .16 0.1824
- 2 ; 9700
PVR
0.7 0.4014 -2'_1104
RAP 8.13 0.0031 1890
CSRF 0,47 0 .493 -2r)tort
C.S0_.
16.229 0 .0001 - 1 16 - .0098
Iacl tut 0 .11 0 .7155 - 2244898
Variables Remalmee In Vode :
Variable Coeileienl SE 7 Score p Val., RR 950 CI
CSO, 0.849 0.2845 2 .9341 1.001 2 .3373 1 .31-4.08
S9P -0_6711 0 .2853 -2 5731 0.02 1.1101 0.29-0.89
PADP 0.1674 0 .2837 2--,3528 0.02 1 .9492 I .C-3,4
15'HA
0,0833 0 .277 1,7464 958 I h'_. 094= 28
1634
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'fable 4 . Variables fur Subgroup,
Willi Low and High Coronary
Sinus G .xygea Conlcnt"
Val. value SD fin paremhesek . "None of the differences
arc significant . Abbreviations as in Tables I and 2.
in patients with congestive heart failure is a more powerful
predictor of survival than are the most commonly used
hemodynamic variables . Patients with coronary artery dis-
ease (grow- 1) who had a high coronary sins ox yger content
had an 85% 1-year survival rate in comparison with a 40%
survival rate of patients in the same group with a low
coronary sinus oxygen content . At 3 years, only 10% of
group I patients with a low coronary sinus oxygen content
were alive compared with 45% of patients with a high
coronary sinus oxygen content . This striking difference
occurred despite a similar mean ejection fraction in the two
subgroups. TFe clinical variables were similar in our patients
with (group I ) and without (group 2) coronary artery disease .
Most patients were in functional class III or IV and were
too
`> 70
so
g 40
i
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a
u 0 50 st
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in, m 100
receiving large doses of furosemide . The distribution of
patients taking an angiotensin-converting enzyme inhibitor,
dlgoxln and hydralazlne or a nitrate, or both was similar in
group I and group 2. All 91 patients had a decreased ejection
fraction and cardiac output and elevated systemic and pul-
monary vascular resistance. Patients with low coronary
sinus oxygen content tended to be sicker. They had lower
cardiac output and higher pulmonary artery diastolic, pul-
monary capillary wedge and right atrial pressure and sys-
temic and pulmonary vascular resistance ; they also tended
to have higher myocardial oxygen consumption ana coro-
nary sinus blood flow. However, these differences did not
reach statistical significance .
Role of systemic hemodynamics . The relation of cause of
congestive heart failure to survival remains controversial
(1,2,11) . We observed similar survival rates in patients
whose congestive heart failure was due to coronary artery
disease (group !) or idiopathic dilated cardiamyopathy
(group 2) . An adverse outcome has been associated with the
severity of symptoms . Patierts in functional class IV have a
poorer survival rate in comparison with patients in class III
(11,12). Our results are consistent with these results ; despite
a p value of 0 .08, our patients with a higher functional class
had a 1 .6-fold increased risk of dying . In our study, a lower
systolic blood pressure was associated with a significant
increased mortality .
Our patients with a lower systolic blood pressure were
probably sicker than those with a higher systolic pressure ; in
fact, when we classified our study patients into two sub-
groups based on mean systolic blood pressure, the patients
with a low systolic blood pressure were receiving a higher
dose of furosemide (142 ± 97 vs. 112 ± 71 mg/day, p m
0 .003) than were those with a higher systolic blood pressure ;
they also tended to have a lower ejection fraction and lower
cardiac output, as well as higher pulmonary capillary wedge
pressure, right atrial pressure and systemic and pulmonary
vascular resistance . Thus, an inappropriately low systemic
blood pressure might decrease the myocardial perfusion
Figure 1. Survival curve for the cohort of 91 patients .
Vanahle
Lao CSO,
154 .441
High CSO.
1>4.44)
Age 64111) 65 (9)
Fare-mid,
(mpdayl 137(87) 125 (91)
NYHA claw fro
II 216 .3%1 215.41
III
11134 .47x) 22(59.5)
IV 19 )59 .470 13 (35.1)
FIR mem,rmim 90 116, 83(211
SDPfmn 11 g) 131128) 139(28)
1)HI'(mmHg)
66191 68(131
PASPImmHe) 65114) 55(191
PADP Imm HFI 31171 25 (8)
PCwr [ .In Hg)
2816) 23 (8)
COllirerdmin)
3 .7 (0.81 4.3(1 .3)
SVR (dyne seocm `I 1 .719(470) 1,652 (636)
PVR )dvro, scccm - `) 33511531 25911691
RAP (mm Hg) (2,2 (5.6) 10.1 (6.3)
MV0, (mhminl 14 .18 01) 10,6614 .3)
CSBF (
.Fmin) 102 (471 101 (48)
Lastane ex1 (7x) 24 (271 25(23)
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Figure 2. Survival curves for patients with high (14A4
vol% ; D) and low (>4 .44 vul'k; OI coronary sinus
oxygen content (generalized Wit-on statistic, p
0.001) .
a
even further. triggering a vicious circle of myocardial hypo-
perfusion leading to more myocardial dysfunction .
Our studv
shows
an increased -iriolirv • assnriirtrd r al,
higher prdaronnrv artery diastolic pre .Varr that probably
reflects the severity of the underlying =c0 ventricular dvs-
function
; in fact, the patients with higher pulmonary artery
diastolic pressure had higher pulmonary capillary wedge
pressure (30 t 7 vs . 19 ± 6 mm Hg, p = O.U03) as well as a
higher furosemide dose requirement (158 ± 91 vs . 100
72 mglday; p <_ 0 .003) . Alternatively . a high pulmonary
artery diastolic pressure might be associated with an in-
creased magnitude of right ventricular dysfunction. The
patients with higher pulmonary artery diastolic pressure also
had significantly higher right atrial pressure 113 .7 ± 6 vs,
8.5 ± 5 mm Hg, p
s
0 .003). These results are consistent with
recent data suggesting that right ventricular dysfunction is an
important determinant of an adverse outcome in patients
with congestive heart failure (13 .14) .
Coronary hemodynamics. In this study. among the cony
nary hemodynamic variables, coronary sinus oxygen con-
tent had the strongest association with survival . The inyo-
Figure 3, Survival curves for the 69 patients in group I
(coronary artery, disease) with high 111 and low (A)
coronary sinus oxygen content and for the 22 patients in
group 2 (idiopathic cardiomyopathy) with high
(C)
and
low (C) coronary sinus oxygen content . High coronary
sinus oxygen content >4 .44 volV4 : low 5444 voWf
(generalized Wfleoxon statistic, p = 11
.11)01) .
so
SO
so 70
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cardial o\yeen consumption was not included in the
proportional hazard model because of inccmpkte data .
However . the model was repeated in analysis of complete
data for 75 patients ; neither myocardial oxygen consump-
tion. coronary sinus blood flow nor lactate extraction
emerged as significant variaMes . .Again . in these 75 patients,
the coronary sinus oxygen content was the most powerful
''ariable for adverse outcome.
A Inn sums -,gen ro ifew irr rltese patients
u-ill, rongr . rior henry faihare probably reflects a compensa-
tory response to an, increased myocardial oxygen require-
men) and possibly to impaired myocardial perfusion . In
congestive heart failure, the myocardial oxygen demand is
increased by several mechanisms. Increased left ventricular
mass, regional or global ventricular hypertrophy and cham-
ber dilation all increase the myocardial oxygen requirement .
Second, the increased sympathetic nervous activity tends to
cause a reflex Increase in contractility and an inappropriate
tachycardia ut rest. Also, in patients with severe congestive
heart failure . there is not only an increased oxygen require-
ment, but also a change in the determinants of myocardial
ao
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I61i
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perfusion
. Because these patients arc often hypotensive and
tachycardic, perfusion flow tends to be impeded further
;
also, an elevated left ventricular diastolic pressure tends to
increase the reduction in suhcndocardial perfusion . Finally,
an abnormal vasodilator reserve has been reported (15) in
some patients with idiopathic dilated cardiomyopathy . Ex-
perimertally . reactive hyperemia with adenosine is blunted
in dogs with left ventricular hypertrophy and failure (161 ;
more r
ecently . i n an animal model of myocardial infarction
(17) . both coronary flow and vasodilatur reserve were de-
creased in the residual noninfurctcd hypertrophied myocar-
dium.
The severity of left ventricular dysfunction and hemody
namic abnormalities is unlikely to be the major determinant
for the differences in the coronary sinus oxygen content in
our study patients. Our patients with a low coronary sinus
oxygen content had clinical and hemndynamie variables
similar to those of patients with higher coronary sinus
oxygen content
. A decrease in the coronary sinus oxygen
Content is expected when coronary blood flow is inadequate
for the myocardial oxygen requirements . A mismatch be-
tween oxygen supply and demand may occur when the
coronary blood flow remains in the normal range or is more
or less titan normal, provided myocardial oxygen demand
exceeds the capacity to provide adequate coronary blood
flow. In nor study, the average coronary blood flow in the
patients with low and higher coronary sinus oxygen content
was similar, suggesting that in the patients with decreased
coronary sinus oxygen content, myocardial oxygen demand
was disproportionately higher . The patients with. ? low
coronary sinus oxygen content tended to have a higher
myocardial oxygen demand (p = NS) ; this result suggests
that a low coronary sinus oxygen content may reflect a
noncompensnted increase in myocardial oxygen demand .
Study limitations, Some limitations of our study need to
be outlined
. It is a retrospective analysis and some data are
incomplete ; left ventricular ejection fraction data were avail-
able in only 63 and complete coronary hemodynamic data in
only 75 of the 91 patients ; for this reason, these variables
were not included in the proportional hazard model . How-
ever, left ventricular ejection fraction was not statistically
different in the two patient subgroups with loty and high
coronary sinus oxygen content
; moreover, myocardial oxy-
gen consumption did not emerge as a significant variable
when the model was repeated for the 75 patients
. The extent
and severity of coronary artery disease were incompletely
studied in our patients with such disease . However, the
coronary flow at rest is usually not compromised even in the
presence of severe coronary artery stenosis ; also . none of
our patients had symptomatic angina . More severe coronary
artery disease would have been associated with decreased
coronary sinus blood flow and decreased coronary sinus
oxygen content. We observed similar coronary sinus blood
flow in patients in the subgroups with low and high coronary
sinus oxygen content ; in addition, it is unlikely that severity
and extent of coronary artery disease explain the increased
mortality in the group with low coronary sinus oxygen
content . The coronary hemodynamic values were measured
at a single point in the clinical course of each patient's
cardiomyopathy ; however, the coronary sinus oxygen con-
tent might be compared with the prognostic value of plasma
norepinephrine in congestive heart failure (18) . In !he study
of Cohn et al . (18), one single sample of venous norepineph-
rine provided a better guide for prognosis than did the heart
rate
. plasma resin activity, serum sodium or stroke work
index . Finally, our group with idiopathic dilated cardiomy-
opathy had a small number of patients and we must be
careful in interpreting the survival data in this group .
Stint, terlmianl imitations ore inherent en studies of
coronary hemodynnrnic technique .
There is always the pos-
sibility of coronary sinus reflux in patients with elevated
right atrial pressure . This potential source of error was
minimized by monitoring changes in coronary sinus blood
temperature during two separate injections of cold saline
solution into the right atrium
. Also, it is possible that the
estimated coronary sinus blood flow and myocardial oxygen
consumption were falsely low. When the catheter is in the
mid-coronary sinus, the estimated coronary flow is more
representative of the great cardiac vein flow and therefore
underestimates the global coronary blood flow . This fact
might explain the lack of prognostic information on survival
provided by these coronary hemodynamic variables.
Conclusions . Congestive heart failure is a complicated
syndrome
. Previous studies have described several indica-
tors of adverse outcome, and have demonstrated that the
magnitude of left and right ventricular dysfunction is one of
the most powerful of these
. Our results demonstrate the
superiority of coronary sinus oxygen content as an indicator
of adverse outcome in patients with end-stage congestive
heart failure, However, coronary sinus catheterization is an
invasive technique and is not without potential complica-
tions
; thus, measurement of the coronary sinus oxygen
content is unlikely to have widespread application in identi-
fying high risk patients, such as those requiring early heart
transplantation . Nevertheless, it appears that in addition to
systemic hemndynamie values, a low coronary sinus oxygen
content is a powerful indicator of adverse outcome in
patients with congestive lean failure ; it probably represents
a compensatory mechanism to prevent myursrdial ischemia
.
which is likely to contribute to the adverse prognosis in this
condition.
We etc grmeful to Gnemn Trcmblay for his nssieance with the data armly,
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